YU49276B - Postupak za dobijanje olanzapina - Google Patents

Postupak za dobijanje olanzapina

Info

Publication number
YU49276B
YU49276B YU17696A YU17696A YU49276B YU 49276 B YU49276 B YU 49276B YU 17696 A YU17696 A YU 17696A YU 17696 A YU17696 A YU 17696A YU 49276 B YU49276 B YU 49276B
Authority
YU
Yugoslavia
Prior art keywords
preparing olanzapine
olanzapine
preparing
dependent
independent
Prior art date
Application number
YU17696A
Other languages
English (en)
Other versions
YU17696A (sh
Inventor
Charles Arthur Bunnell
Barry Arnold Hendriksen
Terrence Michael Hotten
Samuel Dean Larsen
David Edward Tupper
Original Assignee
Eli Lilly And Company
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU49276(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/410,474 external-priority patent/US5631250A/en
Application filed by Eli Lilly And Company, Lilly Industries Limited filed Critical Eli Lilly And Company
Publication of YU17696A publication Critical patent/YU17696A/sh
Publication of YU49276B publication Critical patent/YU49276B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Kristalni mono metanolni solvatni oblik jedinjenja naznačen time, što je dat Formulom I Prijava sadrži još tri nezavisna i sedam zavisnih patentnih zahteva.
YU17696A 1995-03-24 1996-03-22 Postupak za dobijanje olanzapina YU49276B (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40956695A 1995-03-24 1995-03-24
US08/410,474 US5631250A (en) 1995-03-24 1995-03-24 Process and solvate of 2-methyl-thieno-benzodiazepine

Publications (2)

Publication Number Publication Date
YU17696A YU17696A (sh) 1998-07-10
YU49276B true YU49276B (sh) 2005-03-15

Family

ID=27020696

Family Applications (1)

Application Number Title Priority Date Filing Date
YU17696A YU49276B (sh) 1995-03-24 1996-03-22 Postupak za dobijanje olanzapina

Country Status (17)

Country Link
EP (1) EP0733634B1 (sh)
AR (2) AR004169A1 (sh)
AT (1) ATE197711T1 (sh)
AU (1) AU5257896A (sh)
CO (1) CO4700300A1 (sh)
DE (1) DE69611003T2 (sh)
DK (1) DK0733634T3 (sh)
EG (1) EG24221A (sh)
ES (1) ES2151991T3 (sh)
GR (1) GR3035355T3 (sh)
IL (1) IL117613A (sh)
MY (1) MY116503A (sh)
PE (1) PE38197A1 (sh)
PT (1) PT733634E (sh)
SI (1) SI0733634T1 (sh)
WO (1) WO1996030374A1 (sh)
YU (1) YU49276B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2266444C (en) * 1996-09-23 2007-01-09 Eli Lilly And Company Olanzapine dihydrate d
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
ATE500258T1 (de) 2002-05-31 2011-03-15 Sandoz Ag Verfahren zur herstellung von olanzapin form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US7323459B2 (en) 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
CA2551806A1 (en) 2003-12-22 2005-07-14 Teva Pharmaceutical Industries, Ltd. Methods of preparing olanzapine
WO2005080401A1 (en) * 2004-02-19 2005-09-01 Neuland Laboratories Limited Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006073886A1 (en) 2005-01-05 2006-07-13 Eli Lilly And Company Olanzapine pamoate dihydrate
CA2593407A1 (en) * 2007-06-22 2008-12-22 Apotex Pharmachem Inc. Improved processes for the synthesis of olanzapine
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
ATE198891T1 (de) * 1992-05-29 2001-02-15 Lilly Co Eli Thienobenzodiazepinderivate zur behandlung von störungen des zentralnervensystems
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
IL117613A (en) 2000-07-16
EP0733634A1 (en) 1996-09-25
DE69611003T2 (de) 2001-05-10
DE69611003D1 (de) 2000-12-28
WO1996030374A1 (en) 1996-10-03
AR004169A1 (es) 1998-11-04
IL117613A0 (en) 1996-07-23
SI0733634T1 (en) 2001-06-30
YU17696A (sh) 1998-07-10
PT733634E (pt) 2001-04-30
EP0733634B1 (en) 2000-11-22
CO4700300A1 (es) 1998-12-29
MY116503A (en) 2004-02-28
AR002721A1 (es) 1998-04-29
ATE197711T1 (de) 2000-12-15
GR3035355T3 (en) 2001-05-31
PE38197A1 (es) 1997-10-16
AU5257896A (en) 1996-10-16
DK0733634T3 (da) 2000-12-11
ES2151991T3 (es) 2001-01-16
EG24221A (en) 2008-11-10

Similar Documents

Publication Publication Date Title
KR19980701899A (ko) 피리티온 함유 코팅 조성물의 변색 방지법
DK0915898T3 (da) Krystalform I af clarithromycin
AU6613896A (en) Chemical compounds
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
AU7254196A (en) Benzimidazole derivatives as 15-lo inhibitors
AU5485698A (en) Oxyiminopregnancarbolactone
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
YU49276B (sh) Postupak za dobijanje olanzapina
ATE231851T1 (de) 6-o-alkyl erythronolid-b derivate
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
PL330908A1 (en) Inhibitors of prenyl transferases
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
MX9708696A (es) Cefalosporinas antibacterianas.
JO2252B1 (en) Method for preparing pyridine derivatives
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
WO1995025091A3 (en) Nipecotic acid derivatives as antithrombic compounds
MX9606494A (es) Compuestos organicos.
AU7087991A (en) Tricyclic-cyclic amines as novel cholinesterase inhibitors
MX9801190A (es) Inhibidores de prolil endopeptidasa.
AU4479096A (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
IN187760B (sh)
EA199700439A1 (ru) Применение производных пирролидина для лечения алкоголизма
UA41981C2 (uk) Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
DE69620013D1 (de) Zusammensetzungen, die modifizierte polyalkadiene enthalten